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frequencies in African and Asian countries, including Iran. 3 Regardless of the etiology, the majority of CRC are demonstrated to arise from adenoma polyps. There are three forms of adenomatous polyps including tubular histology, villus, and tubular-villus. Although a variety of risk factors, such as viral infections, have been found to involve in the development of CRC, inherited genetic predisposition and molecular mechanisms related to CRC remain under investigation. 4, 5 Viral etiologies of human malignancies are an intriguing subject for basic researchers and clinicians. With the exception of hepatitis C virus, all known human tumor viruses contain DNA as their genetic material. 6 Herpes simplex virus (HSV) and cytomegalovirus (CMV) are ubiquitous herpes viruses that infect and establish persistent infections in the host. A potential role of HSV and CMV in human carcinogenesis has also been investigated in a variety of studies. [7] [8] [9] [10] [11] Available data from clinical studies have so far provided contradictory results, some of which were able to detect the DNA of these viruses in colorectal adenocarcinomas by different laboratory techniques such as insitu hybridization and polymerase chain reaction (PCR). In contrast, others failed to demonstrate the presence of these viruses in tissue samples of CRC, even using the same detection methods. Considering the importance of CRC as the most common gastrointestinal cancer, and the possible role of oncogenic viruses in tumorigenesis, the present study aimed to investigate the prevalence of HSV and CMV in patients with CRC and polyps by the PCR technique, in comparison with healthy subjects. This case-control study was conducted on a total of 35 subjects including 15 patients with CRC and 20 ones with colorectal polyp. Written and informed consent was received from all patients admitted to the Endoscopy Clinic of Toos and Firoozgar Hospitals in Tehran, Iran, between January 2013 and June 2013. Two tissue samples were obtained from each patient, one from malignant tissue and the other from normal colorectal tissue in an area located 15 cm away from the malignant tissue. In addition, 35 samples from patients without malignancy were used as a negative control. Tissue fragments were sampled by endoscopic biopsy, and an average tissue size of 25 mg was calculated for each patient. All collected tissues were kept frozen at −20 °C until analysis.
DNA extraction
DNA was extracted using the KiaSpin ® Tissue Kit (Kiagen CA, Iran) according to the manufacture's instructions. DNA concentrations were determined from absorbance values at a wavelength to 260 nm using a Biophotometer system (Eppendrof, Germany). The ratio of absorbance at 280/260 nm and 230/260 nm was used to assess the purity of DNA. PCR PCR amplification of the human β-globulin gene was carried out to monitor the quality of extracted DNA. The identification of HSV and CMV genomes was performed according to Zaravinos et al. 12 using the specific primers shown in table 1. PCR amplification was performed according in a final volume of 20 µl, containing 10 µl of ×2 prime Taq premix (Kiagen CA, Iran), 3 µl of sterile A statistical analysis was performed using the SPSS software (version 20, SPSS Inc., Chicago, USA). The relationship between the prevalence of HSV and CMV and the occurrence of CRC and polyps were investigated according to the location of the samples and compared with the control group. Tissue samples were analyzed using t-test and χ 2 test. The results were considered to be statistically significant at the 5% level.
In all tissue samples, 106 bp band that represents the amplification of human β-globulin gene observed (Figure 1 ). Due to the quality and reliability of DNA extracted, PCR analysis with HSV and CMV-specific primers was performed; 465 bp bands that represent the replication of HSV (Figure 2) , and 167 bp bands that represent the replication of CMV (Figure 3) .
In 15 patients with CRC, HSV DNA was found in tumor samples of 5 individuals (33.3%), and the normal tissue surrounding the tumor also displayed HSV DNA in 5 ones (33.3%). In contrast, no HSV DNA was found in polyp samples of patients with colorectal polyps (0 out of 20) while 4 (20.0%) of the patients had HSV DNA only in the normal colorectal tissue surrounding the polyp. HSV DNA was found in 7 (20.0%) of 35 patients with non-malignant conditions. Statistical analysis showed that there is no significant association between the prevalence of HSV and the incidence of CRC and polyps according to the location of the samples, as compared with the control group (P = 0.25).
Out of 15 patients with CRC, 8 ones (53.3%) exhibited detectable CMV DNA in their tumor samples, while the normal tissue surrounding the tumor showed that in 10 ones (66.7%). In 5 patients with CRC (33.3%), CMV DNA was found in tumor tissue and matched normal tissue. In 20 patients with colorectal polyps, CMV DNA was detected in the polyp samples of 10 patients (50.0%), and in the normal tissue surrounding the polyp of 14 individuals (70.0%). In 7 patients (35.0%) with polyps, CMV DNA was found to be positive in polyp tissue and matched normal tissue. CMV DNA was identified in 13 (37.1%) of 35 patients with non-malignant conditions. Statistical analysis revealed that there is no significant association between the prevalence of CMV and the incidence of CRC and polyps according to the location of the samples in comparison with the control group (P = 0.28).
We observed the highest prevalence of HSV in CRC patients older than 55 years (26.6%) of age and in the non-malignant control group participants who were over 55 years of age (8.6%) ( Table 2 ). The highest prevalence of CMV was observed in older than 55 years (26.6%) group of CRC patients. In patients with colorectal polyps, the highest prevalence of CMV was observed in two groups, those 35-55 years (25.0%) and over 55 years (25.0%) of age. In the control group, individuals under 35 years (14.3%) had the highest prevalence of CMV (Table 3) . Statistical analysis showed no significant association between the prevalence of HSV and CMV in terms of age in patients with CRC and polyps compared to the control group (P > 0.05) (Tables 2 and 3) .
In terms of gender, the highest prevalence of HSV was observed in male CRC patients (20.0%) and in non-malignant control group women (11.4%) ( We observed the highest prevalence of CMV in male CRC patients (33.3%), in women patients with colorectal polyps (40.0%), and in non-malignant control group women (20.0%) ( Table 3) . Statistical analysis showed no significant association between the prevalence of HSV and CMV and gender in CRC patients and those with polyps compared to the control group (P > 0.05) (Tables 2 and 3) .
The highest prevalence rate according to anatomic location for HSV in CRC patients was the proximal colon (20.0%) and the distal colon (20.0%) in the control group (Table 2) . The highest prevalence rate according to anatomic location for CMV in CRC patients was the proximal colon (26.7%). In patients with polyps, the highest prevalence was the proximal colon (25.0%). The highest prevalence for the control group was the distal colon (37.1%) ( Table 3) . Statistical analysis showed no significant association between the prevalence of HSV and CMV and anatomic location in CRC patients and those with polyps in comparison with the control group (P > 0.05) (Tables 2 and 3) .
In this study, CRC, polyp, and nonmalignant tissues were investigated for the presence of HSV and CMV DNA by the PCR method. In patients with CRC, HSV and CMV DNA were found in 33.3 and 53.3% of the samples, respectively. In patients with colorectal polyps, CMV DNA, but not HSV DNA, was found in 50.0% samples, respectively. In the control group, it was established that 20.0 and 37.1% of the samples were positive for HSV and CMV DNA, respectively. However, data showed that there is no association between the presence of the virus and the occurrence of CRC and polyps when compared with tissues of the control group.
Since the discovery of a viral cause for murine leukemia by Gross, the search for oncogenic viruses has rapidly increased in human malignancies. Based on the current understanding, it is estimated that approximately 15.0% of the global cancer burden can be linked to oncogenic viruses. 13 Oncogenic viruses may contribute to human carcinogenesis favoring genetic instability and inducing chromosomal aberrations. 14 The role of HSV in patients with gastrointestinal cancers, particularly CRC, has yet to be reported in the literature. This is the first study that has investigated the prevalence of HSV in CRC and polyps in Iran.
Various in-vitro studies have demonstrated that the gene products of CMV are able to modulate cell cycle progression and apoptosis by regulating the expression of several important host genes. For example, CMV infection has been shown to transcriptionally activate the expression of the proto-oncogenes c-foc, c-jun, and c-myc. 7 Kalejta and Shenk 8 reported that the CMV UL82 gene product pp71 stimulates cell cycle progression by including protein degradation of another important tumor suppressor Rb and its family members p107 and p130. The possible association of CMV with human colorectal adenocarcinomas was first reported by Huang and Roche 10 who detected CMV DNA in 4 out of 7 colonic adenocarcinomas by membrane complementary RNA-DNA hybridization. Interestingly, CMV DNA was also detected in 1 out of 2 cases of familial adenomatous polyposis, but not in normal colonic tissues from the same patients or control cases of Crohn disease. Furthermore, Harkins et al. 15 detected CMV nucleic acids and proteins in a high proportion of CRC but not in nonneoplastic colonic mucosa. However, in other studies, no evidence of a direct association was found between CRC and HCMV infection. 7, 9 Akintola-Ogunremi et al. 7 attempted to examine 23, 65 and 51 cases of colorectal hyperplastic polyps, colorectal adenomas and colorectal adenocarcinomas, respectively, by immunohistochemical analysis with two different antibodies. No nuclear HCMV antigen positivity was detected in any of the cases studied. In addition, PCR analysis failed to detect viral DNA in 24 selected cases showing non-specific cytoplasmic immunostaning. In a study by Bender et al. 9 on the presence of HCMV in CRC samples, 6 cases (11.0%), of the 56 tested tissue samples, were found to be positive for HCMV nested PCR amplification. More precisely, 1 (5.0%) of 20 cases and 5 (21.0%) of 24 cases were found to be adenoma and moderately differentiated adenocarcinoma, respectively. Surprisingly, no PCR positivity was obtained in samples from well-and poorlydifferentiated adenocarcinomas. Knosel et al. 16 investigated the presence of HCMV DNA and antigens using PCR analysis. 57 primary tumors and 20 metastases of fresh CRC tissue were tested including 13 tumors pairs (primary and metastases) from the same patients. Four (7.0%) of 57 primary tumors were found positive for HCMV DNA by PCR, whereas all metastases were negative.
The results from this study demonstrated that there is no direct molecular evidence to support the association between HSV and CMV with human colorectal malignancies. However, these findings do not exclude the possible oncogenic role for these viruses to infect various colon cells, and their carcinogenesis mechanism needs to be further elucidated.
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